Quality Pharmaceutical Service SRL
Quality Pharmaceutical Service reported total assets of 110,124 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of Quality Pharmaceutical Service shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Quality Pharmaceutical Service's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
Quality Pharmaceutical Service's financial analysis
- Solvency73.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Quality Pharmaceutical Service
Quality Pharmaceutical Service's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1009.819.983
- VAT number
- BE1009819983
- Peppol
- Registered · 0208:1009819983 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 May 2024
- Registered office
- 5081 La Bruyère
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Quality Pharmaceutical Service (SRL) has been based in La Bruyère since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 45,114 € and equity of 80,895 €; its revenue is not published. Its solvency stands at 73.5%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Quality Pharmaceutical Service
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie van Achter Retail sale of pharmaceutical products Ixelles · balance sheet 193,448 €
- Dynaderm Retail sale of pharmaceutical products Wavre · balance sheet 47,613 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Novaplex Retail sale of pharmaceutical products Modave · balance sheet 119,122 €
- Labman Wholesale of pharmaceutical and medical goods Torhout · balance sheet 102,667 €
- T.R.F. pharma Retail sale of pharmaceutical products Fléron · balance sheet 70,151 €
- Sulayman Retail sale of pharmaceutical products Enghien · balance sheet 59,800 €
- Alchemiste Retail sale of pharmaceutical products Aalter · balance sheet 73,555 €
Frequently asked questions about Quality Pharmaceutical Service
What is the revenue of Quality Pharmaceutical Service?
Quality Pharmaceutical Service files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Quality Pharmaceutical Service?
In Belgium, the VAT number is the company number prefixed with BE: BE1009819983 for Quality Pharmaceutical Service, if the company is VAT-registered. Its company number (CBE) is 1009.819.983.
Where is the registered office of Quality Pharmaceutical Service?
According to the CBE register, the registered office of Quality Pharmaceutical Service is in 5081 La Bruyère.
What is the equity of Quality Pharmaceutical Service?
At the close of the 2025 financial year, the equity of Quality Pharmaceutical Service amounts to 80,895 €, a solvency of 73.5% of total assets.
Who manages Quality Pharmaceutical Service?
The register lists 1 active mandates at Quality Pharmaceutical Service. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Quality Pharmaceutical Service
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →